Families' Acceptance, Concerns and Obstacles Towards COVID-19 Vaccine Among Children in Saudi Arabia: A Cross Sectional Survey
Pharmaceutical Science-Pharma
DOI:
https://doi.org/10.22376/ijpbs/lpr.2022.12.5.P162-167Keywords:
Vaccination, Beliefs, Saudi Arabia, Covid-19Abstract
While coronavirus disease 2019 has become a pandemic, the necessity of vaccination is crucial. Early 2020, scientists across the world started their vaccine trials to fight the pandemic. More than 46 million doses of a COVID-19 vaccines have been administered in Saudi Arabia. However, vaccine hesitancy, especially from parents towards their children can be an obstacle. As the parents can be hesitant, they can refuse or deny to vaccinate their children. Our aim is to investigate families' acceptance, concerns, and obstacles related to COVID-19 vaccine among children in Saudi Arabia. Cross-sectional study was conducted from January to April 2022. An online form questionnaire composed of 15 questions was distributed electronically. Our results showed a total of 250 respondents were included in the analysis, of which 78% were female and 22% male aged between 21 to 78 years old. 88% had a university education and 40% was received 3 doses of COVID vaccine, 55.5% received two doses of vaccine, 4% received only one dose and 1% not vaccinated. 64% of parents do not support their children receiving the Corona vaccine, while 36% are supportive of it. This study revealed that many parents were hesitant to give immunity against SARS-CoV-2 to their children. Further educational programs and influence from the social media for parents and community is essential to fight this hesitancy.
References
Alamer E, Alhazmi A, Qasir NA, Alamer R, Areeshi H, Gohal G et al. Side effects of COVID-19 Pfizer-BioNTech mRNA vaccine in children aged 12-18 years in Saudi Arabia. Vaccines. 2021 Nov;9(11):1297. doi: 10.3390/vaccines9111297, PMID 34835228.
Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657-63. doi: 10.2147/JMDH.S276771, PMID 33262600.
Alshahrani SM, Dehom S, Almutairi D, Alnasser BS, Alsaif B, Alabdrabalnabi AA et al. Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey. Hum Vaccin Immunother. 2021 Oct 3;17(10):3338-47. doi: 10.1080/21645515.2021.1936869, PMID 34236290.
Amarilla AA, Sng JDJ, Parry R, Deerain JM, Potter JR, Setoh YX et al. A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses. Nat Commun. 2021 Jun 8;12(1):3431. doi: 10.1038/s41467-021-23779-5, PMID 34103499.
Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL et al. A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2. FEBS Journal. 2020 Sep;287(17):3633-50. doi: 10.1111/febs.15375, PMID 32446285.
Chalise HN. COVID-19 situation and challenges for Nepal. Asia Pac J Public Health. 2020 Jul;32(5):281-2. doi: 10.1177/1010539520932709, PMID 32545991.
Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020 Aug 1;8(8):e1003-17. doi: 10.1016/S2214-109X(20)30264-3.
Fazel M, Puntis S, White SR, Townsend A, Mansfield KL, Viner R et al. Willingness of children and adolescents to have a COVID-19 vaccination: results of a large whole schools survey in England. EClinicalmedicine. 2021 Oct 1;40:101144. doi: 10.1016/j.eclinm.2021.101144, PMID 34608453.
Hill B. Coronavirus: origins, signs, prevention and management of patients. Br J Nurs. 2020 Apr 9;29(7):399-402. doi: 10.12968/bjon.2020.29.7.399, PMID 32279552.
Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, Guaman LP, Kyriakidis NC, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020;98(1):115094. doi: 10.1016/j.diagmicrobio.2020.115094, PMID 32623267.
Izah SC, Chandel SS, Aigberua AO, Venkatachalam T, Verma D. Coronavirus disease 2019: the emergence of popular unverified myths and realities to its spread. Int J Life Sci Pharm Res. 2020;10(5):17-26. Rudan I. A cascade of causes that led to the COVID-19 tragedy in Italy and in other European Union countries. J Glob Health. 2020 Jun;10(1):010335. doi: 10.7189/jogh-10-010335, PMID 32257150.
Tourkmani AM, Bin Rsheed AM, AlEissa MS, Alqahtani SM, AlOtaibi AF, Almujil MS et al. Prevalence of COVID-19 infection among patients with diabetes and their vaccination coverage status in Saudi Arabia: A cross-sectional analysis from a hospital-based diabetes registry. Vaccines. 2022 Feb 16;10(2):310. doi: 10.3390/vaccines10020310, PMID 35214769.
Vinokurova L, Solovyeva V, Filippova V. When ice turns to water: forest fires and indigenous settlements in the republic of Sakha (Yakutia). Sustainability. 2022;14(8):4759. doi: 10.3390/su14084759.
Wang FS, Zhang C. What to do next to control the 2019-nCoV epidemic? Lancet. 2020 Feb 8;395(10222):391-3. doi: 10.1016/S0140-6736(20)30300-7, PMID 32035533.
Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK; et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat Commun. 2021;12(1):29. doi: 10.1038/s41467-020-20226-9, PMID 33397962.
Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D et al. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines. 2021;9(1):42. doi: 10.3390/vaccines9010042, PMID 33445581.
Ward JK, Alleaume C, Peretti-Watel P, COCONEL Group. The French public’s attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Soc Sci Med. 2020;265:113414. doi: 10.1016/j.socscimed.2020.113414, PMID 33038683.
V.D. Tran P, TV, Gribkova EI, Galkina GA, Loskutova EE, Dorofeeva VV et al. Determinants of COVID-19 vaccine acceptance in a high infection-rate country: A cross-sectional study in Russia. Pharm Pract. 2021;19:2276.
Reno C, Maietti E, Fantini MP, Savoia E, Manzoli L, Montalti M et al. Enhancing COVID-19 vaccines acceptance: results from a survey on vaccine hesitancy in Northern Italy. Vaccines. 2021;9(4):378. doi: 10.3390/vaccines9040378, PMID 33924534.
Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC; et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39(7):1148-56. doi: 10.1016/j.vaccine.2020.12.083, PMID 33461834.
van der Linden S, Dixon G, Clarke C, Cook J. Inoculating against COVID-19 vaccine misinformation. EClinicalmedicine. 2021;33:100772. doi: 10.1016/j.eclinm.2021.100772, PMID 33655205.
Bhartiya S, Kumar N, Singh T, Murugan S, Rajavel S, Wadhwani M. Knowledge, attitude and practice towards COVID-19 vaccination acceptance in West India. Int J Community Med Public Health. 2021;8:7.
Alshaikhli H, Al-Naggar RA, Al-Maktari L, Madram S, Al-Rashidi RR. Epidemiology of Covid-19. In: Yemen: a descriptive study. International Journal of Life science and Pharma Research (IJLPR). Vol. 10(5); 2020 Dec 1. p. 134-8.
Nexøe J, Kragstrup J, Søgaard J. Decision on influenza vaccination among the elderly. A questionnaire study based on the Health Belief Model and the Multidimensional Locus of Control Theory. Scand J Prim Health Care. 1999;17(2):105-10. doi: 10.1080/028134399750002737, PMID 10439494.
Coe AB, Gatewood SBS, Moczygemba LR, Goode JV, Beckner JO. The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine. Innov Pharm. 2012;3(2):1-11. doi: 10.24926/iip.v3i2.257, PMID 22844651.
Mo PKH, Lau JTF. Influenza vaccination uptake and associated factors among elderly population in Hong Kong: the application of the Health Belief Model. Health Educ Res. 2015;30(5):706-18. [Cr. doi: 10.1093/her/cyv038, PMID 26336905.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Lamya Abdullah Almatrafi, Refal Essam Fagieha, Mohammed Abdulmuti Simsim, Alaa H. Falemban, Safaa M. Alsanosi, Deena Bukhary, Yosra AL -Hindi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
